| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | KRG | United States | $26.31 | $844,365,000.00 | Buy | 10 | 2004 |
#2 | RSI | United States | $24.28 | $1,134,428,000.00 | Strong Buy | 10 | 2020 |
#3 | IVT | United States | $33.25 | $299,169,000.00 | Buy | 7 | 2005 |
#4 | TREE | United States | $31.64 | $1,117,324,000.00 | Strong Buy | 4 | 2008 |
#5 | PAGP | United States | $25.15 | $44,262,000,000.00 | Buy | 10 | 2013 |
#6 | OOMA | United States | $20.14 | $114,490,000.00 | Strong Buy | 4 | 2015 |
#7 | LEVI | United States | $22.46 | $6,282,000,000.00 | Strong Buy | 12 | 2019 |
#8 | VCYT | United States | $44.68 | $0.00 | Strong Buy | 7 | 2013 |
#9 | BXMT | United States | $14.28 | $0.00 | Buy | 5 | 1998 |
#10 | APEI | United States | $45.13 | $198,174,000.00 | Strong Buy | 7 | 2007 |
#11 | DRVN | United States | $12.45 | $1,862,438,000.00 | Buy | 8 | 2020 |
#12 | DRH | United States | $12.23 | $1,120,491,000.00 | Buy | 10 | 2004 |
#13 | SIRI | United States | $28.44 | $5,425,129,000.00 | Buy | 8 | 1996 |
#14 | PCRX | United States | $23.70 | $541,533,000.00 | Strong Buy | 4 | 2010 |
#15 | LINC | United States | $30.16 | $261,853,000.00 | Strong Buy | 4 | 2005 |
#16 | ALHC | United States | $13.53 | $3,948,719,000.00 | Buy | 8 | 2021 |
#17 | SI | United States | $19.34 | $47,317,000.00 | Strong Buy | 5 | 2025 |
#18 | CTRE | United States | $39.16 | $476,393,000.00 | Buy | 10 | 2013 |
#19 | MPLT | United States | $11.38 | $0.00 | Strong Buy | 7 | 2025 |
#20 | PECO | United States | $40.14 | $726,594,000.00 | Buy | 7 | 2010 |
#21 | AROC | United States | $33.28 | $1,489,818,000.00 | Strong Buy | 6 | 2007 |
#22 | CALY | United States | $16.53 | $2,060,100,000.00 | Buy | 4 | 1994 |
#23 | BIOA | United States | $10.48 | $8,995,000.00 | Strong Buy | 6 | 2024 |
#24 | PRVA | United States | $21.54 | $2,122,842,000.00 | Buy | 12 | 2021 |
#25 | CSV | United States | $33.69 | $417,440,000.00 | Strong Buy | 4 | 1996 |
#26 | HCSG | United States | $20.80 | $1,837,173,000.00 | Buy | 6 | 1994 |
#27 | UTI | United States | $25.64 | $835,616,000.00 | Strong Buy | 4 | 2003 |
#28 | KDP | United States | $29.59 | $16,603,000,000.00 | Buy | 15 | 2007 |
#29 | CRTO | France | $17.36 | $2,296,692,000.00 | Strong Buy | 10 | 2013 |
#30 | NAMS | Netherlands | $27.83 | $22,503,000.00 | Strong Buy | 8 | 2022 |
#31 | ROOT | United States | $48.27 | $1,517,100,000.00 | Buy | 5 | 2020 |
#32 | TNGX | United States | $25.58 | $62,384,000.00 | Strong Buy | 10 | 2020 |
#33 | GTX | Switzerland | $29.34 | $3,584,000,000.00 | Strong Buy | 5 | 2021 |
#34 | NI | United States | $41.98 | $0.00 | Buy | 10 | 2018 |
#35 | SBRA | United States | $20.19 | $774,632,000.00 | Buy | 8 | 2010 |
#36 | TCMD | United States | $24.51 | $0.00 | Strong Buy | 4 | 2016 |
#37 | TDC | United States | $26.74 | $2,156,000,000.00 | Buy | 9 | 2007 |
#38 | PGNY | United States | $25.42 | $1,288,661,000.00 | Buy | 10 | 2019 |
#39 | ROL | United States | $36.52 | $2,161,220,000.00 | Buy | 11 | 1994 |
#40 | BRX | United States | $29.73 | $1,371,597,000.00 | Buy | 12 | 2013 |
#41 | MAC | United States | $24.65 | $1,013,983,000.00 | Buy | 12 | 1994 |
#42 | HST | United States | $22.80 | $5,387,000,000.00 | Buy | 14 | 1998 |
#43 | GTY | United States | $32.88 | $221,727,000.00 | Buy | 5 | 1998 |
#44 | RDN | United States | $36.44 | $1,197,084,000.00 | Buy | 6 | 2008 |
#45 | LOCO | United States | $15.20 | $401,701,000.00 | Buy | 4 | 2014 |
#46 | MNST | United States | $45.98 | $8,294,343,000.00 | Buy | 15 | 1996 |
#47 | GLPI | United States | $43.10 | $1,594,752,000.00 | Buy | 11 | 2013 |
#48 | VVV | United States | $33.30 | $2,285,000,000.00 | Buy | 15 | 2016 |
#49 | CNP | United States | $40.53 | $9,357,000,000.00 | Buy | 13 | 2001 |
#50 | EE | United States | $35.75 | $1,228,263,000.00 | Buy | 5 | 2022 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $50 to Buy (August 13, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.